These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3742732)

  • 1. Fecapentaene-12 causes DNA damage and mutations in human cells.
    Plummer SM; Grafstrom RC; Yang LL; Curren RD; Linnainmaa K; Harris CC
    Carcinogenesis; 1986 Sep; 7(9):1607-9. PubMed ID: 3742732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecapentaene causes sister-chromatid exchanges in human lymphocytes.
    Bauchinger M; Bartha R; Schmid E; Pfaendler HR
    Mutat Res; 1988; 209(1-2):29-31. PubMed ID: 3173400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxic mechanisms of fecapentaene-12 in human cells.
    Povey AC; Plummer SM; Grafstrom RC; Harris CC
    Prog Clin Biol Res; 1990; 347():155-66. PubMed ID: 2217387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography.
    de Kok TM; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1991 Feb; 12(2):199-205. PubMed ID: 1995185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of fecapentaene-12 toward thiols, DNA, and these constituents in human fibroblasts.
    Dypbukt JM; Edman CC; Sundqvist K; Kakefuda T; Plummer SM; Harris CC; Grafström RC
    Cancer Res; 1989 Nov; 49(21):6058-63. PubMed ID: 2790820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncovalent DNA binding and the mechanism of oxidative DNA damage by fecapentaene-12.
    Szekely J; Gates KS
    Chem Res Toxicol; 2006 Jan; 19(1):117-21. PubMed ID: 16411664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory and epidemiologic studies of fecapentaenes.
    Povey AC; Schiffman M; Taffe BG; Harris CC
    Mutat Res; 1991; 259(3-4):387-97. PubMed ID: 2017218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fecapentaenes on nuclear aberrations in murine colonic epithelial cells.
    Vaughan DJ; Furrer R; Baptista J; Krepinsky JJ
    Cancer Lett; 1987 Oct; 37(2):199-203. PubMed ID: 3677054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal mutagen fecapentaene-12 damages mammalian colon epithelial DNA.
    Hinzman MJ; Novotny C; Ullah A; Shamsuddin AM
    Carcinogenesis; 1987 Oct; 8(10):1475-9. PubMed ID: 3652384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model study of fecapentaenes: mutagens of bacterial origin with alkylating properties.
    Gupta I; Suzuki K; Bruce RW; Krepinsky JJ; Yates P
    Science; 1984 Aug; 225(4661):521-3. PubMed ID: 6377497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of colorectal cancer and fecapentaene excretion.
    Schiffman MH; Van Tassell RL; Robinson A; Smith L; Daniel J; Hoover RN; Weil R; Rosenthal J; Nair PP; Schwartz S
    Cancer Res; 1989 Mar; 49(5):1322-6. PubMed ID: 2917361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization and quantitative analysis of fecapentaenes in human feces, using synthetic fecapentaene-12.
    Kleinjans JC; Pluijmen MH; Hageman GJ; Verhagen H
    Cancer Lett; 1989 Jan; 44(1):33-7. PubMed ID: 2917340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study on the effects of fecal composition on fecapentaene kinetics in the large bowel.
    de Kok TM; van Iersel ML; ten Hoor F; Kleinjans JC
    Mutat Res; 1993 Jun; 302(2):103-8. PubMed ID: 7684504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivorous and vegetarian diets.
    de Kok TM; van Faassen A; Bausch-Goldbohm RA; ten Hoor F; Kleinjans JC
    Cancer Lett; 1992 Feb; 62(1):11-21. PubMed ID: 1540928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of 8-hydroxydeoxyguanosine in DNA treated with fecapentaene-12 and -14.
    Shioya M; Wakabayashi K; Yamashita K; Nagao M; Sugimura T
    Mutat Res; 1989 Mar; 225(3):91-4. PubMed ID: 2927433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On distribution of different fecapentaenes, the fecal mutagens, in the human population.
    Baptista J; Bruce WR; Gupta I; Krepinsky JJ; van Tassell RL; Wilkins TD
    Cancer Lett; 1984 Apr; 22(3):299-303. PubMed ID: 6713371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecapentaenes and their precursors throughout the bowel--results of an autopsy study.
    Schiffman MH; Bitterman P; Viciana AL; Schairer C; Russell L; Van Tassell RL; Wilkins TD
    Mutat Res; 1988 May; 208(1):9-15. PubMed ID: 3367931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity tests of fecapentaene-12 in mice and rats.
    Weisburger JH; Jones RC; Wang CX; Backlund JY; Williams GM; Kingston DG; Van Tassell RL; Keyes RF; Wilkins TD; de Wit PP
    Cancer Lett; 1990 Feb; 49(2):89-98. PubMed ID: 2306713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity of fecapentaene-12 in bacterial and mammalian cell assay systems.
    Curren RD; Putman DL; Yang LL; Haworth SR; Lawlor TE; Plummer SM; Harris CC
    Carcinogenesis; 1987 Feb; 8(2):349-52. PubMed ID: 3542273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fecapentaenes, potent mutagens from human feces.
    Kingston DG; Van Tassell RL; Wilkins TD
    Chem Res Toxicol; 1990; 3(5):391-400. PubMed ID: 2133089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.